R Taipa1,2,3, V Ferreira2,3, P Brochado1, A Robinson4, I Reis1, F Marques2,3, D M Mann4, M Melo-Pires1, N Sousa2,3. 1. Neuropathology Unit, Department of Neurosciences, Centro Hospitalar do Porto, Porto, Portugal. 2. Life and Health Sciences Research Institute, University of Minho, Braga, Portugal. 3. ICVS/3B's Associate Lab, PT Government Associated Lab, Braga/Guimarães, Portugal. 4. Division of Neuroscience and Experimental Psychology, Faculty of Biology, Medicine and Health, School of Biological Sciences, Salford Royal Hospital Foundation NHS Trust, University of Manchester, Salford, UK.
Abstract
AIMS: The association between the pathological features of AD and dementia is stronger in younger old persons than in older old persons suggesting that additional factors are involved in the clinical expression of dementia in the oldest old. Cumulative data suggests that neuroinflammation plays a prominent role in Alzheimer's disease (AD) and different studies reported an age-associated dysregulation of the neuroimmune system. Consequently, we sought to characterize the pattern of microglial cell activation and astrogliosis in brain post mortem tissue of pathologically confirmed cases of early and late onset AD (EOAD and LOAD) and determine their relation to age. METHODS: Immunohistochemistry (CD68 and glial fibrillary acidic protein) with morphometric analysis of astroglial profiles in 36 cases of AD and 28 similarly aged controls. RESULTS: Both EOAD and LOAD groups had higher microglial scores in CA1, entorhinal and temporal cortices, and higher astroglial response in CA1, dentate gyrus, entorhinal and temporal cortices, compared to aged matched controls. Additionally, EOAD had higher microglial scores in subiculum, entorhinal and temporal subcortical white matter, and LOAD higher astrogliosis in CA2 region. CONCLUSIONS: Overall, we found that the neuroinflammatory pathological markers in late stage AD human tissue to have a similar pattern in both EOAD and LOAD, though the severity of the pathological markers in the younger group was higher. Understanding the age effect in AD will be important when testing modifying agents that act on the neuroinflammation.
AIMS: The association between the pathological features of AD and dementia is stronger in younger old persons than in older old persons suggesting that additional factors are involved in the clinical expression of dementia in the oldest old. Cumulative data suggests that neuroinflammation plays a prominent role in Alzheimer's disease (AD) and different studies reported an age-associated dysregulation of the neuroimmune system. Consequently, we sought to characterize the pattern of microglial cell activation and astrogliosis in brain post mortem tissue of pathologically confirmed cases of early and late onset AD (EOAD and LOAD) and determine their relation to age. METHODS: Immunohistochemistry (CD68 and glial fibrillary acidic protein) with morphometric analysis of astroglial profiles in 36 cases of AD and 28 similarly aged controls. RESULTS: Both EOAD and LOAD groups had higher microglial scores in CA1, entorhinal and temporal cortices, and higher astroglial response in CA1, dentate gyrus, entorhinal and temporal cortices, compared to aged matched controls. Additionally, EOAD had higher microglial scores in subiculum, entorhinal and temporal subcortical white matter, and LOAD higher astrogliosis in CA2 region. CONCLUSIONS: Overall, we found that the neuroinflammatory pathological markers in late stage AD human tissue to have a similar pattern in both EOAD and LOAD, though the severity of the pathological markers in the younger group was higher. Understanding the age effect in AD will be important when testing modifying agents that act on the neuroinflammation.
Authors: Sreemathi Logan; Gordon H Royce; Daniel Owen; Julie Farley; Michelle Ranjo-Bishop; William E Sonntag; Sathyaseelan S Deepa Journal: Geroscience Date: 2019-10-22 Impact factor: 7.713
Authors: Giovanni B Frisoni; Daniele Altomare; Dietmar Rudolf Thal; Federica Ribaldi; Rik van der Kant; Rik Ossenkoppele; Kaj Blennow; Jeffrey Cummings; Cornelia van Duijn; Peter M Nilsson; Pierre-Yves Dietrich; Philip Scheltens; Bruno Dubois Journal: Nat Rev Neurosci Date: 2021-11-23 Impact factor: 34.870
Authors: Daniel S Albrecht; Abhay Sagare; Maricarmen Pachicano; Melanie D Sweeney; Arthur Toga; Berislav Zlokovic; Helena Chui; Elizabeth Joe; Lon Schneider; John C Morris; Tammie Benzinger; Judy Pa Journal: Brain Behav Immun Date: 2021-01-22 Impact factor: 7.217
Authors: Edward S Wickstead; Husnain A Karim; Roberta E Manuel; Christopher S Biggs; Stephen J Getting; Simon McArthur Journal: Oxid Med Cell Longev Date: 2020-06-13 Impact factor: 6.543
Authors: Daniel Felsky; Tina Roostaei; Kwangsik Nho; Shannon L Risacher; Elizabeth M Bradshaw; Vlad Petyuk; Julie A Schneider; Andrew Saykin; David A Bennett; Philip L De Jager Journal: Nat Commun Date: 2019-01-24 Impact factor: 14.919
Authors: Yan Liu; John Man Tak Chu; Tim Yan; Yan Zhang; Ying Chen; Raymond Chuen Chung Chang; Gordon Tin Chun Wong Journal: J Neuroinflammation Date: 2020-01-03 Impact factor: 8.322